Cosmo to Participate in Upcoming Investor Conferences

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/10/2026

1. SPY
2. USO
3. META
4. MSFT
5. MU
6. COST
7. IONS
8. CG
9. AVAV
10. SKHY

February 18, 2026 1:03 AM EST

Dublin, Ireland--(Newsfile Corp. - February 18, 2026) - Cosmo Pharmaceuticals N.V. (Cosmo) is pleased to announce its participation in the following upcoming investor conferences:

UBS European Healthcare Conference 2026
London, United Kingdom
4 March 2026
Svetlana Sigalova, Chief Financial Officer, will participate in one-on-one meetings with investors.

Jefferies Biotech Summit 2026
Miami, United States
11 March 2026
Giovanni Di Napoli, Chief Executive Officer, will participate in one-on-one meetings with investors.

TP ICAP Healthcare Conference
Paris, France
7 May 2026
Members of the management team will participate in meetings with investors.

Investors attending any of the above conferences who would like to meet with Cosmo are welcome to contact the Companys IR team to arrange an appointment via [email protected].

About Cosmo
Cosmo is a life sciences company focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). We design, develop, and manufacture advanced solutions that address critical medical needs and raise the standard of care. Our technologies are trusted by leading global pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. Guided by our purpose - Building Health Confidence - our mission is to empower patients, healthcare professionals, and partners by innovating at the intersection of science and technology. Founded in 1997, Cosmo is headquartered in Dublin, Ireland, with offices in San Diego (USA), and in Lainate, Rome, and Catania (Italy). For more information, visitwww.cosmohealthconfidence.com.

For further information, please contact:
[email protected]

Attachments
PDF - English

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/284298


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Newsfile, Press Releases

Related Entities

UBS, Jefferies & Co, Maynard Um, Mark Zuckerberg, ARK